The regressive tumor WT01 carried GLI3 Q1437*, the triphasic WT02 harbored MAX R60Q and MYCN T58M mutations, and the blastemal WT03 showed a heterozygous DIS3L2 deletion and a STK32C V339M mutation. Here, DIS3L2 is linked to neoplasm.